ASIC1 gene expression in glioma cells can predict outcomes of carcinomas as they act as genomic biomarkers; therefore, finding more inhibitors to ASICs may provide potential therapeutic agents to inhibit glioma cell activity (Sun et al., 2013; Bychkov et al., 2020; Griffin et al., 2020). The gene discussed is ASIC1; the disease is glioma.